Effect of morphine and naloxone on release of the excitatory amino acids of spinal astrocytes induced by TNF-α

  • Xiang Hongbing
  • Tian Yuke
  • Sun Yi
Article

Summary

The effect of morphine and naloxone on release of the excitatory amino acids (EAAs) of spinal astrocytes induced by TNF-α was studied. Astrocytes were purified from 2- to 3-day old SD rats and divided into 8 groups: group 1 (without any stimulatants); group 2 (10 ng/ml TNF-α); group3 (10 ng/ml TNF-α+0.5 μmol/L morphine); group 4 (10 ng/ml TNF-α+1.0 μmol/L morphine); group 5 (10 ng/ml TNF-α+2.0 μmol/L morphine); group 6 (10 ng/ml TNF-α+0.5 μmol/L naloxone); group 7 (10 ng/ml TNF-α+1.0 μmol/L naloxone); group 8 (10 ng/ml TNF-α +2.0 μmol/L naloxone). In group 2, 3, 4 and 5, 0, 0.5, 1.0 or 2.0 μmol/L morphine was added to the cells cultured with serum-free Neurobasal/B27 medium containing 10 ng/ml TNF-α respectively, while in group 6, 7 and 8, 0.5, 1.0 or 2.0 μmol/L naloxone was added respectively to the cells cultured with serum-free Neurobasal/B27 medium containing 10 ng/ml TNF-α. After 30 min incubation, high-pressure liquid chromatography (HPLC) was used to measure the levels of EAAs in all cultured cells. The results showed the level of EAAs in group 2 was significant higher than in group 1 (P<0.01). As compared with group 2, the levels of EAAs in group 3, 4 and 5 were decreased with the difference being significant between group 5 and group 2 (P<0.01) or between group 4 and group 2 (P<0.05). The levels of EAAs in group 6, 7 and group 8 was significantly lower than in group 2 (P<0.05 orP<0.01). It was concluded that TNF-α could promote the release of glutamate and aspartate from astrocytes, and morphine and naloxone might reduce the release of EAAs in cultured spinal astrocytes induced by TNF-α.

Key words

tumor necrosis factor-α astrocyte glutamate aspartate naloxone morphine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Watkins L R, Milligan E D, Maier S F. Glial activation: a driving force for pathological pain. Trends Neurosci, 2001,24:450PubMedCrossRefGoogle Scholar
  2. 2.
    Zhao Z F, Liu Q Y, Zhu C G. Excitative effect of TNF-α-activated astrocytic conditioned medium on hippocapal neurons. Chin J Anat (Chinese), 2002,25(3):205Google Scholar
  3. 3.
    McCarthy K D, Devellis J. Preparation of separate astroglial and oligodendroglial cultures from rat cerebral tissue. J Cell Biol, 1980,85(3):890PubMedCrossRefGoogle Scholar
  4. 4.
    Watkins L R, Milligan E D, Maier S F. Spinal cord glial: new players in pain. Pain, 2001,93:201PubMedCrossRefGoogle Scholar
  5. 5.
    Bianchi L, Colivicchi M A, Bolam J Pet al. The release of amino acids from rat neostriatum and substantia nigra in vivo: a dual microdialysis probe analysis. Neuroscience, 1998,87(1):171PubMedCrossRefGoogle Scholar
  6. 6.
    Hopkins S J, Rothwell N J. Cytokines and the nervous system. I: Expression and recognition. Trends Neurosci, 1995,18(2):83PubMedCrossRefGoogle Scholar
  7. 7.
    Diehl J A, Tong W, Sun Get al. Tumor necrosis factor-alpha-dependent activation of a RelA homodimer in astrocytes. Increased phosphorylation of RelA and MAD-3 precede activation of RelA. J Biol Chem, 1995, 270(6):2703PubMedCrossRefGoogle Scholar

Copyright information

© Springer 2005

Authors and Affiliations

  • Xiang Hongbing
    • 1
  • Tian Yuke
    • 1
  • Sun Yi
    • 1
  1. 1.Department of Anesthesiology, Tongji Hospital, Tongji Medical CollegeHuazhong University of Science and TechnologyWuhanChina

Personalised recommendations